Telegram-Icon YouTube-Icon whatsapp-Icon

Search Stock:

Glaxosmithkline Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages

Glaxosmithkline Pharmaceuticals Share Price

Symbol: GLAXO
Share Price: ₹3,050.10
▼ 56.30 (1.81%)
Open ₹3,106.50
Day High ₹3,120.00
Day Low ₹3,035.20
Prev. Close ₹3,106.40
Volume 205,702

Price on NSE

Glaxosmithkline Pharmaceuticals Share Price

Symbol: GLAXO (BSE Code: 500660)
Share Price: ₹3,053.10
▼ 53.00 (1.71%)
Open ₹3,120.60
Day High ₹3,120.60
Day Low ₹3,040.10
Prev. Close ₹3,106.10
Volume 3,431

Price on BSE

Glaxosmithkline Pharmaceuticals (GLAXO (BSE Code: 500660)) Key Ratios

P/E
Company48.02
Sector7.4
A Price-to-Earnings of 48.02 means investors pay 48.02 units per 1 unit of earnings. This is higher than the sector average of 7.4.
P/B
Company22.62
Sector4.36
A P/B ratio of 22.62 shows market value relative to book value. This is higher than the sector average of 4.36.
ROA
Company24.7%
Sector-17.84%
Return on Assets shows a 24.7% profit per unit of asset. This is higher than the sector average of -17.84%.
ROE
Company45.69%
Sector-2.58%
Return on Equity creates 45.69% profit per unit of equity. This is higher than the sector average of -2.58%.
ROCE
Company61.23%
Sector6.43%
ROCE indicates 61.23% operating earnings per unit of capital. This is higher than the sector average of 6.43%.
Quick Ratio
Company1.77
Sector6.85
The Quick Ratio is 1.77 compared to sector average 6.85.
EV/EBITDA
Company32.14
Sector14.92
EV/EBITDA of 32.14 means value is 32.14 times core earnings. This is higher than the sector average of 14.92.

Glaxosmithkline Pharmaceuticals Share Price Analysis API (Live)

Glaxosmithkline Pharmaceuticals share price is ₹3,050.10, day high (share price) is ₹3,120.00, day low (share price) is ₹3,035.20 and volume is 205,702. 52 Week high share price for Glaxosmithkline Pharmaceuticals is ₹3,120.70 on 28 Aug 2026 and 52 week low share price for Glaxosmithkline Pharmaceuticals is ₹2,088.10 on 12 Jun 2026. Price data as of: 31 Aug, 2026 3:31 PM.

According to latest price data (as of 31 Aug, 2026 3:31 PM) for Glaxosmithkline Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 70.8 (O.Bought), 50 DMA (50 Displaced Moving Average) is 2,610.49 and 200 DMA (200 Displaced Moving Average) is 2,472.23.

3,050.10
-56.30 (-1.81%)
As of 31 Aug, 2026
Open ₹3,106.50
Day High - Low ₹3,120.00 - ₹3,035.20
Volume 205,702
52 Weeks High ₹3,120.70 on 28 Aug 2026
52 Weeks Low ₹2,088.10 on 12 Jun 2026
RSI (14) 70.8 (O.Bought)
50 DMA 2,610.49
200 DMA 2,472.23
Loading...

Glaxosmithkline Pharmaceuticals (GLAXO) Technical Analysis

₹3,050.10 -56.30
31 Aug, 2026

Glaxosmithkline Pharmaceuticals Technical Data and Analysis available in multiple timeframes.

Glaxosmithkline Pharmaceuticals Oscillators Analysis

On the Day timeframe, the outlook for GLAXO is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 70.8.

Glaxosmithkline Pharmaceuticals Price Action

Glaxosmithkline Pharmaceuticals Oscillators Overview

IndicatorValue
RSI (14)70.81
Stoch %K (14, 3, 3)91.77
CCI (20)96.13
ADX (14)42.99
Awesome Osc347.93
Momentum (10)347.20
MACD (12, 26, 9)140.49
MACD Signal120.47
Stoch RSI (14)57.35
Williams %R (14)-13.05
Bull/Bear Power285.44
Ultimate Osc56.76
MFI (14)89.11
ROC (21)14.86
ROC (125)14.99
ATR (14)85.99

Glaxosmithkline Pharmaceuticals Moving Averages

GLAXO is trading above 14 out of 14 SMAs.
3,050.10
CURRENT PRICE
Bullish Moving Averages
14
Bearish Moving Averages
0
5 SMA3,044.68
8 SMA3,007.13
9 SMA3,009.93
10 SMA2,996.68
12 SMA2,946.54
20 SMA2,812.26
21 SMA2,805.12
26 SMA2,768.61
30 SMA2,735.08
34 SMA2,705.31
50 SMA2,610.49
100 SMA2,470.63
150 SMA2,468.64
200 SMA2,472.23
Ichimoku Base2,807.40Above Base
VWMA (20)2,946.35Above VWMA
HMA (9)3,104.46Below HMA

Glaxosmithkline Pharmaceuticals Technical SWOT Analysis

STRENGTHS
  • Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
  • Price is above the 50 DMA, suggesting supportive medium-term trend structure.
  • MACD is above the signal line and in positive territory, reflecting supportive momentum.
WEAKNESSES
  • No notable technical weakness signals are currently observed.
OPPORTUNITIES
  • No specific opportunity signals are identified; the setup appears neutral.
THREATS
  • RSI is overbought, which may increase the likelihood of short-term consolidation or pullback.

Glaxosmithkline Pharmaceuticals Daily Pivot Points (Support & Resistance)

Level Classic Woodie's Camarilla Fibonacci
Resistance 33,186.473,233.703,073.423,153.23
Resistance 23,153.233,176.853,065.653,120.84
Resistance 13,101.673,148.903,057.873,100.83
Pivot Point3,068.433,092.053,050.103,068.43
Support 13,016.873,064.103,042.333,036.04
Support 22,983.633,007.253,034.553,016.03
Support 32,932.072,979.303,026.782,983.63
Daily Historical Technical Data of Glaxosmithkline Pharmaceuticals
Records:
Date Close ADX PDI MDI Aroon Up Aroon Down Bollinger UB Bollinger MB Bollinger LB CCI CMF MACD Signal MFI PSAR RSI (F) RSI Sto (F) %K %D Supertrend Ult Osc Wil %R
Synchronizing oscillators history...
Daily Historical Moving Averages of Glaxosmithkline Pharmaceuticals
Records:
Date Close SMA(5)EMA(5)SMA(8)EMA(8)SMA(9)EMA(9)SMA(10)EMA(10)SMA(12)EMA(12)SMA(20)EMA(20)SMA(21)EMA(21)SMA(26)EMA(26)SMA(30)EMA(30)SMA(34)EMA(34)SMA(50)EMA(50)SMA(100)EMA(100)SMA(150)EMA(150)SMA(200)EMA(200) Ichimoku Base VWMA(20) HMA(9)
Synchronizing moving averages history...

Glaxosmithkline Pharmaceuticals Share Price Performance (NSE)

Period LTP Chg % Absolute Chg Prev LTP Result
1 Week
₹3,050.10
31 Aug 2026, Mon
-0.62% ₹-19.00
₹3,069.10
27 Aug 2026, Thu
Bearish
1 Month
₹3,050.10
31 Aug 2026, Mon
+14.57% +₹387.80
₹2,662.30
3 Aug 2026, Mon
Bullish
3 Months
₹3,050.10
31 Aug 2026, Mon
+39.85% +₹869.10
₹2,181.00
3 Jun 2026, Wed
Bullish
6 Months
₹3,050.10
31 Aug 2026, Mon
+20.43% +₹517.50
₹2,532.60
2 Mar 2026, Mon
Bullish
9 Months
₹3,050.10
31 Aug 2026, Mon
+21.09% +₹531.20
₹2,518.90
3 Dec 2025, Wed
Bullish
1 Year
₹3,050.10
31 Aug 2026, Mon
+9.84% +₹273.20
₹2,776.90
3 Sep 2025, Wed
Bullish
2 Years
₹3,050.10
31 Aug 2026, Mon
+7.70% +₹217.95
₹2,832.15
3 Sep 2024, Tue
Bullish
3 Years
₹3,050.10
31 Aug 2026, Mon
+112.06% +₹1,611.80
₹1,438.30
1 Sep 2023, Fri
Bullish
4 Years
₹3,050.10
31 Aug 2026, Mon
+112.74% +₹1,616.35
₹1,433.75
2 Sep 2022, Fri
Bullish
5 Years
₹3,050.10
31 Aug 2026, Mon
+101.81% +₹1,538.75
₹1,511.35
3 Sep 2021, Fri
Bullish

Glaxosmithkline Pharmaceuticals - Shareholding Pattern

Historical breakdown of ownership percentages over time.

Category Jun 2026 Mar 2026 Dec 2025 Sep 2025
Promoters 75.00% 75.00% 75.00% 75.00%
FII 4.79% 4.62% 4.64% 4.80%
DII (Other) 2.93% 2.95% 2.93% 2.70%
Retail & Others 12.41% 12.69% 12.66% 12.45%
Mutual Funds 4.87% 4.73% 4.77% 5.05%

Glaxosmithkline Pharmaceuticals - Yearly Income Statement (in ₹ Crore)

Period Revenue Operating Profit Net Profit
Mar 2026 3,967.03 +1.85% 1,406.01 +11.6% 1,035.98 +11.69%
Mar 2025 3,895.14 +8.92% 1,259.88 +54.36% 927.58 +57.23%
Mar 2024 3,576.30 +6.68% 816.19 -2.42% 589.96 -3.39%
Mar 2023 3,352.38 836.40 610.69

Glaxosmithkline Pharmaceuticals - Corporate Actions

Type Ex-Date Amount / Ratio Details
Dividend 29 May 2026 ₹57 View Details
Announcement date 13 May 2026
Ex dividend date 29 May 2026
Record date 29 May 2026
Dividend type Final
Amount 57.0
Dividend % 570.0
Details Rs.57.0000 per share(570%)Final Dividend

Glaxosmithkline Pharmaceuticals Share Price and Volume Historical Data

Synchronizing MarketBandhu Database...